STAT3 is constitutively activated in cancer cells and tumor microenvironment cells due to overactivation of cytokine and growth factor pathways, which is caused by receptor and non-receptor tyrosine kinase mutations and the defects of SOCS protein (Wingelhofer et al., 2018; Liu et al., 2023). Here, STAT3 is linked to cancer.